Overall Survival in Patients With Advanced Melanoma Who Received Nivolumab Versus Investigator's Choice Chemotherapy in CheckMate 037: A Randomized, Controlled, Open-Label Phase III Trial.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Adil Daud Paul Lorigan Sandra P D'Angelo Jeffrey S Weber Bart Neyns Bartosz Chmielowski Dirk Schadendorf |
| Publication date | July 3, 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |